Developer of a noninvasive implant solution for transcatheter Left Atrial Appendage (LAA) exclusion, Apend Medical has announced the completion of a €6.2 million ($7.4m) Series A financing round.
The round was led by MedTecX LP along with an unnamed strategic company and other investors and included a $700K of matching grant from the Israel Innovation Authority.
WHY IT MATTERS
Append Medical,...
